Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five

Merih T Tesfazghi1,2, Anne R Bass3, Noor Al-Hammadi4

  • 1Department of Pathology and Immunology, Washington University in St Louis, St Louis, MO, USA.

Insights

Cardiac risk scores modestly predicted myocardial injury after noncardiac surgery (MINS) in men undergoing hip or knee arthroplasty. Baseline high-sensitivity cardiac troponin I (hs-cTnI) effectively predicted MINS in both sexes.

Area of Science:

  • Cardiology
  • Orthopedic Surgery
  • Geriatric Medicine

Background:

  • Elderly patients undergoing hip or knee arthroplasty face risks of myocardial injury after noncardiac surgery (MINS).
  • Assessing cardiac risk is crucial for optimizing patient outcomes in this demographic.

Purpose of the Study:

  • To evaluate the predictive ability of five common cardiac risk scores for MINS.
  • To assess the correlation of these scores with postoperative hs-cTnI levels.
  • To determine the utility of baseline hs-cTnI in predicting MINS.

Main Methods:

  • Ancillary study to the GIFT trial involving patients aged 65+ undergoing elective hip or knee arthroplasty.
  • Evaluation of ASCVD, FRS, ACS-NSQIP, RCRI, and R-RCRI risk scores.
  • Analysis of baseline and postoperative day 2 (POD2) hs-cTnI levels.

Main Results:

  • No cardiac risk scores predicted MINS in women.
  • ASCVD, ACS-NSQIP, and RCRI scores predicted MINS in men.
  • All risk scores correlated with POD2 hs-cTnI levels.
  • Baseline hs-cTnI predicted MINS in both women (C-statistic 0.63) and men (C-statistic 0.72).

Conclusions:

  • Cardiac risk scores showed modest predictive value for MINS in men undergoing arthroplasty.
  • Baseline hs-cTnI is a significant predictor of MINS in this patient population.
  • Risk stratification for MINS may benefit from incorporating hs-cTnI levels.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
284
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
130
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
188
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
106